Information for "CasirivimabImdevimab treatment is linked to extremely low rates associated with a hospital stay amongst highrisk patients using mild to average coronavirus disease19"
From EECH Central
Basic information
Display title | CasirivimabImdevimab treatment is linked to extremely low rates associated with a hospital stay amongst highrisk patients using mild to average coronavirus disease19 |
Default sort key | CasirivimabImdevimab treatment is linked to extremely low rates associated with a hospital stay amongst highrisk patients using mild to average coronavirus disease19 |
Page length (in bytes) | 3,233 |
Page ID | 1311029 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Roomzone7 (Talk | contribs) |
Date of page creation | 08:31, 28 March 2024 |
Latest editor | Roomzone7 (Talk | contribs) |
Date of latest edit | 08:31, 28 March 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |